NCT06312618View on ClinicalTrials.gov

Propofol Versus Dexmedetomidine Effect on Prevention Emergence Agitation

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

March 15, 2025

Study Completion Date

March 15, 2025

Conditions
Emergence Agitation
Interventions
DRUG

Propofol

"After completion of the procedure and after regain muscle power sevoflurane administration will be ceased. children will be randomized to receive propofol~1mg/kg over 10 minutes (group 1) ."

DRUG

Dexmedetomidine

After completion of the procedure and after regain muscle power sevoflurane administration will be ceased. children will be randomized to receive dexmedetomidine 0.2 mcg/kg over 10 minutes (group 2).

Trial Locations (1)

11517

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06312618 - Propofol Versus Dexmedetomidine Effect on Prevention Emergence Agitation | Biotech Hunter | Biotech Hunter